XOMA Stock Price, Chart, Stats & News

XOMA Royalty Corp.
Save
XOMA Royalty Corp. (XOMA) does not currently pay a dividend.
528.60M
Market cap
100.36x
Current P/E
20.45x
Forward P/E
XOMA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 94.32% |
Operating margin | 21.83% |
Pretax margin | 61.01% |
Net margin | 56.40% |
Effective tax rate | 0.32% |
ROA | 10.79% |
ROE | 30.24% |
D/E | 1.27x |
Interest coverage ratio | 0.87x |
XOMA valuation
P/E | 100.36x |
P/S | 6.89x |
P/B | 5.25x |
P/CF | 195.60x |
P/FCF | 128.70x |
P/OCF | 195.60x |
PEG | 0.21x |
EV multiple | 21.63x |
About
XOMA Royalty Corp. functions as a specialist in aggregating biotechnology royalties, with its operations extending across Europe, the United States, and the Asia Pacific region. The company is dedicated to fostering advancements in human health by collaborating with biotechnology firms. Its core business model involves acquiring the anticipated future economic benefits, such as royalties and milestone payments, associated with pre-market therapeutic candidates that have already been licensed to pharmaceutical or biotechnology firms.
Similar securities
Based on sector and market capitalization
Report issue











